BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7627268)

  • 1. Characteristics of prolactin secretion in normal and estrogen-treated pituitaries of rats at the single cell level: analysis by reverse hemolytic plaque assay.
    Yoshikawa M; Uozumi T; Kawamoto K; Arita K; Ito A; Takahashi S
    Endocr J; 1995 Apr; 42(2):235-43. PubMed ID: 7627268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related alterations in prolactin secretion by individual cells as assessed by the reverse hemolytic plaque assay.
    Larson GH; Wise PM
    Biol Reprod; 1991 Apr; 44(4):648-55. PubMed ID: 1904281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic estrogen treatment in male rats reveals mammosomatotropes and allows inhibition of prolactin secretion by somatostatin.
    Goth MI; Lyons CE; Ellwood MR; Barrett JR; Thorner MO
    Endocrinology; 1996 Jan; 137(1):274-80. PubMed ID: 8536623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes.
    Livingstone JD; Lerant A; Freeman ME
    Neuroendocrinology; 1998 Sep; 68(3):172-9. PubMed ID: 9734001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid augmentation of prolactin cell number and secretory capacity by an estrogen-induced factor released from the neurointermediate lobe.
    Ellerkmann E; Nagy GM; Frawley LS
    Endocrinology; 1991 Aug; 129(2):838-42. PubMed ID: 1906805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyperprolactinemia on luteinizing hormone and prolactin secretion assessed using the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Biol Reprod; 1989 Oct; 41(4):618-25. PubMed ID: 2695175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute recruitment of prolactin-secreting cells is regulated posttranscriptionally.
    Porter TE; Ellerkmann E; Frawley LS
    Mol Cell Endocrinol; 1992 Mar; 84(1-2):23-31. PubMed ID: 1379199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
    Kimura N; Hayafuji C; Konagaya H; Takahashi K
    Endocrinology; 1986 Sep; 119(3):1028-36. PubMed ID: 2874016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion and release of prolactin from rat pituitaries and pituitary tumors in vitro.
    Kendall ME; Lawson DM
    Proc Soc Exp Biol Med; 1988 Dec; 189(3):291-6. PubMed ID: 3205881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of galanin in the anterior pituitary of estrogen-treated Fischer 344 rats: autocrine and paracrine regulation of prolactin secretion.
    Cai A; Bowers RC; Moore JP; Hyde JF
    Endocrinology; 1998 May; 139(5):2452-8. PubMed ID: 9564857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of prolactin and growth hormone production in hyperplastic and neoplastic rat pituitary tissues by the hemolytic plaque assay.
    Lloyd RV; Coleman K; Fields K; Nath V
    Cancer Res; 1987 Feb; 47(4):1087-92. PubMed ID: 3542200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries.
    Aguilar R; Bellido C; Garrido-Gracia JC; Alonso R; Sánchez-Criado JE
    Reproduction; 2006 Apr; 131(4):763-9. PubMed ID: 16595727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin does not inhibit prolactin synthesis in normal male rat pituitary cells but inhibits prolactin synthesis in estradiol-primed pituitary cells.
    Lee SC; Shin SH
    J Endocrinol; 1996 Jan; 148(1):69-76. PubMed ID: 8568473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats.
    Jarry H; Leonhardt S; Schmidt WE; Creutzfeldt W; Wuttke W
    Life Sci; 1992; 51(11):823-30. PubMed ID: 1522745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP; Nguyen DN; Smith SG; Freeman ME
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive and regulated prolactin secretion: effects of estradiol.
    Larson GH; Wise PM
    Biol Reprod; 1994 Feb; 50(2):357-62. PubMed ID: 8142551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen increases the release of epidermal growth factor from individual pituitary cells in female rats.
    Mouihate A; Lestage J
    J Endocrinol; 1995 Sep; 146(3):495-500. PubMed ID: 7595145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.
    Luque EH; Munoz de Toro M; Smith PF; Neill JD
    Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.